XBiotech Inc. (XBIT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to…
Source: Yahoo Finance
Sector & Industry
XBiotech Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
XBiotech Inc. at a Glance
| Company | XBiotech Inc. |
| Ticker | XBIT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.20 |
| Market cap | $67.07M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.48 |
| 52-week high | $3.44 |
| 52-week low | $2.09 |
| Dividend yield | — |
| Ex-dividend date (last paid) | 15 Jul 2021 |
| Beta | 0.85 |
| Return on equity (ROE) | -29.94% |
| Debt-to-equity | — |
| Average volume | 40,033 |
| Shares outstanding | 30.49M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 87 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is XBiotech Inc.'s current P/E ratio?
- XBiotech Inc. (XBIT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is XBiotech Inc.'s market capitalisation?
- XBiotech Inc.'s market cap is $67.07M based on our latest snapshot. See how it ranks by market cap →
- What is XBIT's 52-week range?
- Over the past 52 weeks, XBIT has traded between $2.09 and $3.44. What does the 52-week range mean? →
- How volatile is XBiotech Inc. compared to the market?
- XBiotech Inc. has a beta of 0.85, meaning it has historically moved less than the broader market. What does beta measure? →
- Does XBiotech Inc. pay a dividend?
- XBiotech Inc. does not currently pay a dividend according to our latest data.
- What exchange is XBIT listed on?
- XBIT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is XBiotech Inc. in?
- XBiotech Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →